Imbria Pharmaceuticals, Inc.

Form D Filings

Location
Boston, MA
Industry Group
Biotechnology
Entity Type
Corporation
CIK
0001745672
All SEC Filings
View on sec.gov
Date Filed Security Types Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
4/1/2025 Equity $59,195,818 $124,195,815 $64,999,997 3/10/2025 4/1/2025 D 000174567225000003
7/2/2020 Equity, Security to be Acquired $40,734,932 $80,734,932 $40,000,000 6/22/2020 7/2/2020 D 000171369520000004
7/9/2018 Equity $40,249,995 $40,249,995 $0 7/2/2018 7/6/2018 D 000174567218000001